Abstract
Salicylamide-C14 has been prepared in this laboratory from C14 salicylic acid.
The major urinary metabolite after the oral administration of 300 mgm. of the drug to cancer patients was identified as the ethereal glucuronide of salicylamide. A small and extremely variable amount of the original drug also was recovered in the urine. No other metabolite could be detected.
No metabolite of salicylic acid was detected, indicating that the substance was not converted to salicylic acid and that the pharmacological action could not be due to the latter substance.
Footnotes
- Received August 15, 1952.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
A STUDY OF THE METABOLISM OF Cl4 SALICYLAMIDE IN THE HUMAN
